TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats

por Mohanan, Anookh, Gupta, Ram, Dubey, Amita, Jagtap, Vikrant, Mandhare, Appaji, Gupta, Ramesh C., Chauthaiwale, Vijay, Dutt, Chaitanya
Publicado 2011

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

por Zambad, Shitalkumar P, Tuli, Davinder, Mathur, Anoop, Ghalsasi, Sameer A, Chaudhary, Anita R, Deshpande, Shailesh, Gupta, Ramesh C, Chauthaiwale, Vijay, Dutt, Chaitanya
Publicado 2013

TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats

por Zambad, Shitalkumar P, Munshi, Siralee, Dubey, Amita, Gupta, Ram, Busiello, Rosa Anna, Lanni, Antonia, Goglia, Fernando, Gupta, Ramesh C, Chauthaiwale, Vijay, Dutt, Chaitanya
Publicado 2011

Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis

por Gupta, Ram, Chaudhary, Anita R, Shah, Binita N, Jadhav, Avinash V, Zambad, Shitalkumar P, Gupta, Ramesh Chandra, Deshpande, Shailesh, Chauthaiwale, Vijay, Dutt, Chaitanya
Publicado 2014

The Effect of a Diiodothyronine Mimetic on Insulin Sensitivity in Male Cardiometabolic Patients: A Double-Blind Randomized Controlled Trial

por van der Valk, Fleur, Hassing, Carlijne, Visser, Maartje, Thakkar, Purav, Mohanan, Anookh, Pathak, Kaushal, Dutt, Chaitanya, Chauthaiwale, Vijay, Ackermans, Mariette, Nederveen, Aart, Serlie, Mireille, Nieuwdorp, Max, Stroes, Erik
Publicado 2014